P834: REAL-WORLD EVIDENCE OF SAFETY AND EFFECTIVENESS OF ECULIZUMAB AND SWITCH TO RAVULIZUMAB IN A SWISS PATIENT POPULATION WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

por Rovó, A., Simeon, L., Gavillet, M., Samii, K., Cantoni, N., Heim, D., Stüssi, G., Bissig, M.
Publicado 2022

Sideroblastic changes of the bone marrow can be predicted by the erythrogram of peripheral blood

por ROVÓ, A, STÜSSI, G, MEYER-MONARD, S, FAVRE, G, TSAKIRIS, D, HEIM, D, HALTER, J, ARBER, C, PASSWEG, J, GRATWOHL, A, TICHELLI, A
Publicado 2010

Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study

por Greenfield, D. M., Salooja, N., Peczynski, C., van der Werf, S., Schoemans, H., Hill, K., Cortelezzi, A., Lupo-Stangellini, M., Özkurt, Z. N., Arat, M., Metzner, B., Turlure, P., Rovo, A., Socié, G., Mohty, M., Nagler, A., Kröger, N., Dreger, P., Labopin, M., Han, T. S., Tichelli, A., Duarte, R., Basak, G., Snowden, J. A.
Publicado 2021